ClearPoint Neuro Inc.ClearPoint Neuro Inc.ClearPoint Neuro Inc.

ClearPoint Neuro Inc.

No trades
See on Supercharts
Market capitalization
‪151.34 M‬USD
−0.90USD
‪−22.09 M‬USD
‪23.96 M‬USD
‪23.65 M‬
Beta (1Y)
1.58

About ClearPoint Neuro Inc.

CEO
Joseph Michael Burnett
Headquarters
Solana Beach
Employees (FY)
107
Founded
1998
ISIN
US18507C1036
FIGI
BBG000Q39HV3
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CLPT is 5.75 USD — it has increased by 2.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ClearPoint Neuro Inc. stocks are traded under the ticker CLPT.
ClearPoint Neuro Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ClearPoint Neuro Inc. has a max estimate of 11.00 USD and a min estimate of 9.00 USD.
CLPT earnings for the last quarter are −0.20 USD whereas the estimation was −0.25 USD which accounts for 20.00% surprise. Estimated earnings for the next quarter are −0.20 USD. See more details about ClearPoint Neuro Inc. earnings.
ClearPoint Neuro Inc. revenue for the last quarter amounts to ‪5.76 M‬ USD despite the estimated figure of ‪6.73 M‬ USD. In the next quarter revenue is expected to reach ‪6.53 M‬ USD.
Yes, you can track ClearPoint Neuro Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, CLPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ClearPoint Neuro Inc. stock right from TradingView charts — choose your broker and connect to your account.
CLPT reached its all-time high on Jul 3, 2012 with the price of 200.00 USD, and its all-time low was 1.33 USD and was reached on Dec 26, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 107.00 employees. See our rating of the largest employees — is ClearPoint Neuro Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ClearPoint Neuro Inc. EBITDA is ‪−20.99 M‬ USD, and current EBITDA margin is −87.62%. See more stats in ClearPoint Neuro Inc. financial statements.